EPAS1 and chromophobe renal cell carcinoma: We characterized 2916 clear cell RCC-specific and 4564 chromophobe RCC- specific EPAS1-binding sites through performing EPAS1 ChIP on eight additional primary human tumors (n = 2 chRCC; n = 6 ccRCC, Fig. 3D).